Drugs / E1M184V peptide
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00381875 | Jul 2006 → Feb 2011 | — | National Institutes of Health Clinical Center (CC) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | E1M184V peptide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00381875 ↗ |
| Modality | Vaccine | “a Peptide Vaccine for HIV Infected HLA-A2 Individuals” NCT00381875 ↗ |